Join
Live feed
·
INSIDERFilingvia Quantisnow
Opiant Pharmaceuticals Inc. logo

SEC Form 4: Ellison Mark Jason Heath returned $608,620 worth of shares to the company (30,431 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
OPNT· Opiant Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPNT (Opiant Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Ellison Mark Jason Heath returned $608,620 worth of shares to the company (30,431 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the company | Quantisnow